fda warning letters compounded semaglutide tirzepatide 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of GLP-1 Drugs and Telehealth Providers 🚨 FDA Moves to Permanently

Specific variants in GLP1R, GIPR, and FTO genes may affect how an individual's body processes GLP-1 agonists and manages weight regulation

Among the all semaglutide OW cohort and subgroups (1: persistent [ 60-day gap in semaglutide OW supply]

Furthermore, while the study controlled for several confounding factors, unmeasured variables could have influenced the results

In a controlled trial involving healthy older women, twice-daily consumption of a protein beverage enriched with ~4 g of leucine elicited significantly greater increases in both acute and integrated myofibrillar protein synthesis compared with an isonitrogenous mixed-protein beverage containing lower leucine content